KitoINK is a ULB spin-off project in the development phase, dedicated to advanced chitosan-based bioinks for 3D bioprinting applications in regenerative medicine and drug discovery.
Our platform enables the formulation of tunable, light-responsive bioinks designed to recreate physiologically relevant 3D microenvironments. By allowing precise control over mechanical properties, viscoelastic behaviour, and degradation kinetics, KitoINK supports the fabrication of stable and reproducible cell-laden constructs.
The technology aims to facilitate the development of disease-specific and patient-specific 3D cell culture models that better recapitulate native tissue conditions compared to conventional 2D systems. Such models are intended to improve the predictive value of in vitro studies in drug screening, toxicity assessment, and mechanistic disease research.